Theralase Technologies Inc. V.TLT

$TLTFF Data to date is the data that goes to the FDA

[floatinketucky]

Then they sit around drink coffee chew the fat and make decisions.
Those decissions are then released to the public.

Right now the FDA is looking at the latest Data to date. Not data from before 29 NOV 2021!

What's that data trend? That's your friend. 
The Data is on the side of Theralase.

Very very very soon. We will hear.  JMO
_____________________________________

As a Fast Track designee, Theralase® will have access to early and frequent communications with the FDA to discuss Theralase’s development plans and ensure timely collection of the appropriate clinical data to support the approval process.
November 23, 2020

------------------------------------------------------------------

Shawn Shirazi went on to say, "In a 3Q2019 conference call with the FDA, it was discussed and agreed between the FDA and the Company, that Theralase would potentially be eligible for Fast Track Approval ("FTA") post receipt of the FDA IND authorization, based on the clinical study data collected to date. It was further discussed and agreed that Theralase would potentially be eligible for Breakthrough Therapy Designation ("BTD") and / or Accelerated Approval ("AA"), if Theralase can demonstrate clinically significant results (high safety profile and high efficacy response), similar to the safety and efficacy results observed in the Phase Ib NMIBC clinical study (high safety profile and 67% CR) at an interim analysis of approximately 20 to 25 patients enrolled and successfully treated."

Its all about the DATA TO DATE